PROM1 and glioblastoma: To evaluate the impact of PIM1 inhibition on GBM stem cell features, we examined the expression of CD133, since several studies have demonstrated a close correlation between the expression of the stem cell marker CD133, chemoresistance and GBM survival [37,46,47].